|
PSMA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36439999998128E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.40249947608606E-10 |
| Normal-vs-Stage2 |
6.458500E-03 |
| Normal-vs-Stage3 |
6.721300E-03 |
| Normal-vs-Stage4 |
9.145400E-01 |
| Stage1-vs-Stage2 |
1.915580E-01 |
| Stage1-vs-Stage3 |
4.118300E-02 |
| Stage1-vs-Stage4 |
7.63460000000604E-05 |
| Stage2-vs-Stage3 |
6.972000E-01 |
| Stage2-vs-Stage4 |
3.010300E-02 |
| Stage3-vs-Stage4 |
3.260100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41559999994523E-06 |
| Normal-vs-AfricanAmerican |
1.615950E-04 |
| Normal-vs-Asian |
8.122800E-01 |
| Caucasian-vs-AfricanAmerican |
1.833830E-01 |
| Caucasian-vs-Asian |
1.746570E-01 |
| AfricanAmerican-vs-Asian |
7.371900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07519999995132E-06 |
| Normal-vs-Female |
3.028100E-04 |
| Male-vs-Female |
5.494200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.677560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.51810999999835E-05 |
| Normal-vs-Age(61-80Yrs) |
5.66469999999653E-05 |
| Normal-vs-Age(81-100Yrs) |
1.625390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.047200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.330200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.358000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.066600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.096800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.349600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.42509998141338E-09 |
| Normal-vs-Grade 2 |
4.38689995441166E-09 |
| Normal-vs-Grade 3 |
5.68629999999626E-05 |
| Normal-vs-Grade 4 |
2.847200E-01 |
| Grade 1-vs-Grade 2 |
8.160100E-04 |
| Grade 1-vs-Grade 3 |
1.159060E-04 |
| Grade 1-vs-Grade 4 |
7.89459997374564E-09 |
| Grade 2-vs-Grade 3 |
2.355000E-01 |
| Grade 2-vs-Grade 4 |
2.31739999999592E-05 |
| Grade 3-vs-Grade 4 |
5.550800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.82049988604194E-11 |
| Normal-vs-ccB subtype |
1.318370E-02 |
| ccA subtype-vs-ccB subtype |
4.137300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.214900E-04 |
| Normal-vs-N1 |
6.680600E-01 |
| N0-vs-N1 |
7.418400E-02 |
|
|
